🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is designed to provide data about the 24 hours FEV1 profile, saf...
Status
Completed
Location
Novartis Investigator Site
Start Date
2007-11
Trial ID
NCT00557440
The purpose of the study is to determine the appropriate dose of fluticason...
Status
Completed
Location
Research Site
Start Date
2006-11
Trial ID
NCT00403286
A once-daily 'closed' triple FDC therapy of FF/UMEC/VI via a single ELLIPTA...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-10-13
Trial ID
NCT02924688
This is a multi-centre, randomised, double-blind, double-dummy, two way cro...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-11-14
Trial ID
NCT01978145
The purpose of this study is to compare the effectiveness and safety of ind...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-02
Trial ID
NCT01555138
Treatments Being Tested
The primary objective of this study is to evaluate the dose response, effic...
Status
Completed
Location
Teva Investigational Site 10453
Start Date
2013-01
Trial ID
NCT01772368
Treatments Being Tested
This is a prospective study. It enrolls subjects with allergic rhinitis, wi...
Status
Not Yet Recruiting
Location
Huiying Wang
Start Date
2025-08
Trial ID
NCT07114107
The aim of the present study is to investigate whether the effects of salme...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-08
Trial ID
NCT00517634
The primary objective of the trial is to show superiority in lung function ...
Status
Completed
Location
Jasper Summit Research, LLC
Start Date
2017-08-14
Trial ID
NCT03240575
Treatments Being Tested
A new formulation of Fluticasone propionate/Salmeterol comparing a lower do...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-01-28
Trial ID
NCT00364442
Treatments Being Tested